Garrett; Michelle Dawn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Garrett; Michelle Dawn.The latest application filed is for "5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof".

Company Profile

0.7.8

Garrett; Michelle Dawn - Sutton GB
Garrett; Michelle Dawn - Surrey GB
Garrett; Michelle Dawn - Walton-on-Thames GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof App 20210276990 - Collins; Ian ; et al.	2021-09-09
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Grant 10,259,806 - Collins , et al.	2019-04-16
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof App 20180022739 - Collins; Ian ; et al.	2018-01-25
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]py- razine-2-carbonitrile and therapeutic uses thereof Grant 9,663,503 - Collins , et al. May 30, 2	2017-05-30
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]py- Razine-2-carbonitrile And Therapeutic Uses Thereof App 20150126471 - Collins; Ian ; et al.	2015-05-07
Purine and deazapurine derivatives as pharmaceutical compounds Grant 8,796,293 - Davies , et al. August 5, 2	2014-08-05
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators Grant 8,541,461 - Thompson , et al. September 24, 2	2013-09-24
Pharmaceutical compounds Grant 8,343,953 - Davies , et al. January 1, 2	2013-01-01
Pharmaceutical Combinations Comprising Pyrazole Derivatives As Protein Kinase Modulators App 20100166699 - Thompson; Neil Thomas ; et al.	2010-07-01
Pharmaceutical Compounds App 20100130464 - Davies; Thomas Glanmor ; et al.	2010-05-27
Purine And Deazapurine Derivatives As Pharmaceutical Compounds App 20100022564 - Davies; Thomas Glanmor ; et al.	2010-01-28
Pharmaceutical Compounds App 20090253718 - Davies; Thomas Glanmor ; et al.	2009-10-08
Pharmaceutical Combinations of PK Inhibitors and Other Active Agents App 20090082370 - Thompson; Neil Thomas ; et al.	2009-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.